6:00 PM Mumbai – Aurobindo Pharma received final approval from the U.S. regulators for its anti-depressant capsules. Clariant agree to acquire Plastichemix for Rs 135 crore. Glaxo surged after the parent company plans to raise its stake to 75%. SpiceJet signed agreement with Singapore-based Tigerair.
The Sensex Index fell 56.06 to close at 20,659.52. The CNX Nifty slid 13.70 to close at 6,154.70.
Gainers & Losers
Aurobindo Pharma Ltd
surged 12.6 to Rs 348.95 after the company received the final approval from U.S. Food & Drug Administration to manufacture and market Duloxetine Hydrochloride, an anti-depressant capsule.
Clariant Chemicals (India) Limited
dropped 2.6% to Rs 628.25 after the company agree to acquire Vadodara-based Plastichemix Industries for Rs 135 crore.
Essar Ports Limited
slid 0.3% to Rs 56.45 after the company’s subsidiary signed agreement with Visakhapatnam Port Trust for development and operations of three iron ore berths.
GlaxoSmithKline Pharmaceuticals Limited
soared 18.6% to Rs 2,927.40 after the parent company GSK plans to raise its stake from 50.7% to up to 75% or 2.06 crore shares through an open offer at a price of Rs 3,100 per share in its domestic unit.
surged 7.6% to Rs 16.90 after the company signed three-year agreement with Singapore-based discount carrier Tigerair.
State Bank of India
slid 0.6% to Rs 1,732.85 after the bank reduced its advance tax payment for the December quarter.
Tata Chemicals Limited
slipped 1.2% to Rs 264.10 after the Reserve Bank of India imposed limits to new foreign investor stake purchase.
Tata Consultancy Services Limited
gained 0.7% to Rs 2,017.30.